These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12111961)
41. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study. Runge VM; Kirsch JE; Wells JW; Woolfolk CE AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562 [TBL] [Abstract][Full Text] [Related]
42. Human cerebral blood volume measurements using dynamic contrast enhancement in comparison to dynamic susceptibility contrast MRI. Artzi M; Liberman G; Nadav G; Vitinshtein F; Blumenthal DT; Bokstein F; Aizenstein O; Ben Bashat D Neuroradiology; 2015 Jul; 57(7):671-8. PubMed ID: 25845809 [TBL] [Abstract][Full Text] [Related]
43. [Quantitative evaluation of myocardial perfusion with ultrafast magnetic resonance tomography]. Machnig T; Koroneos A; Engels G; Bachmann K; Simm C; Wilke N; Ellermann J; Zhang J; Ya X; Merkel H Z Kardiol; 1994 Nov; 83(11):840-50. PubMed ID: 7825374 [TBL] [Abstract][Full Text] [Related]
44. Cerebral blood flow, blood volume, and oxygen metabolism dynamics in human visual and motor cortex as measured by whole-brain multi-modal magnetic resonance imaging. Donahue MJ; Blicher JU; Østergaard L; Feinberg DA; MacIntosh BJ; Miller KL; Günther M; Jezzard P J Cereb Blood Flow Metab; 2009 Nov; 29(11):1856-66. PubMed ID: 19654592 [TBL] [Abstract][Full Text] [Related]
46. Perfusion precision in bolus-tracking MRI: estimation using the wild-bootstrap method. Calamante F; Connelly A Magn Reson Med; 2009 Mar; 61(3):696-704. PubMed ID: 19097234 [TBL] [Abstract][Full Text] [Related]
47. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T. Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539 [TBL] [Abstract][Full Text] [Related]
48. In vivo determination of absolute cerebral blood volume using hemoglobin as a natural contrast agent: an MRI study using altered arterial carbon dioxide tension. Ulatowski JA; Oja JM; Suarez JI; Kauppinen RA; Traystman RJ; van Zijl PC J Cereb Blood Flow Metab; 1999 Jul; 19(7):809-17. PubMed ID: 10413037 [TBL] [Abstract][Full Text] [Related]
52. Longitudinal mapping of mouse cerebral blood volume with MRI. Moreno H; Hua F; Brown T; Small S NMR Biomed; 2006 Aug; 19(5):535-43. PubMed ID: 16552789 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging. Perkiö J; Aronen HJ; Kangasmäki A; Liu Y; Karonen J; Savolainen S; Østergaard L Magn Reson Med; 2002 May; 47(5):973-81. PubMed ID: 11979577 [TBL] [Abstract][Full Text] [Related]
54. Differentiation of gray matter and white matter perfusion in patients with unilateral internal carotid artery occlusion. Kluytmans M; van der Grond J; Folkers PJ; Mali WP; Viergever MA J Magn Reson Imaging; 1998; 8(4):767-74. PubMed ID: 9702876 [TBL] [Abstract][Full Text] [Related]
55. CBF and CBV measurements by USPIO bolus tracking: reproducibility and comparison with Gd-based values. Simonsen CZ; Ostergaard L; Vestergaard-Poulsen P; Røhl L; Bjørnerud A; Gyldensted C J Magn Reson Imaging; 1999 Feb; 9(2):342-7. PubMed ID: 10077035 [TBL] [Abstract][Full Text] [Related]